undamentalytics Newsletter

CME Group revenue

CME Group's revenue was $6.52bn in fiscal 2025, up 6.4% on the year before. Since fiscal 2009 ($2.61bn) it has grown at a compound 5.9% a year. Over the last twelve months it was $6.97bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

CME Group: revenue history, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue2,6133,0043,2812,9152,9363,1133,3273,5953,6454,3094,8684,8844,6905,0195,5796,1306,5216,972
Growth on the year before—+15.0%+9.2%−11.2%+0.7%+6.0%+6.9%+8.1%+1.4%+18.2%+13.0%+0.3%−4.0%+7.0%+11.1%+9.9%+6.4%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Clearingandtransactionfees $5.3B 81.0% ▲ 5.9%
Market Data $803M 12.3% ▲ 13.1%
Other Revenue $436M 6.7% ▲ 1.1%

From CME Group's 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Financial Exchanges & Data: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
CME Group $6.97bn 9.0% 9.2%
Moody's Corporation $8.18bn 9.0% 12.6%
Coinbase $5.63bn -26.6% 26.5%
Nasdaq, Inc. $9.15bn 11.5% 15.1%
Cboe Global Markets $5.28bn 14.3% 11.5%
Intercontinental Exchange $14.05bn 12.1% 13.5%

Compare with peers

Head to head: CME vs MCOCME vs COINCME vs NDAQCBOE vs CME

More: Financial Exchanges & Data stocks compared, Financials sector, rankings of US companies

Figures from CME Group's SEC filings (10-K and 10-Q), retrieved October 24, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to CME Group.